Genetic Medicine with Small Molecules
Serna Bio is developing small molecules to modulate RNA function, unlocking the potential to treat diseases driven by biology intractable by other modalities.
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
What they do:
Altay develops disease-modifying therapies targeting transcription…
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$15.7M · Equity · Oct 2026
What they do:
Arpeggio Bio develops drugs targeting transcription factors using AI…
Quick facts:
HQ: Boulder, CO, United States
What they do:
The next generation of induced-proximity medicines.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Discovering drugs that target the DNA regulome
Quick facts:
HQ: Seattle, WA, United States
What they do:
Using CRISPR to find treatments for cancer and inflammation
Quick facts:
HQ: San Francisco, CA, United States
Genetic Medicine with Small Molecules
San Francisco, CA, United States
5 employees, according to the company profile.
There are no funding rounds for Serna Bio in our data.
Similar startups: Numerion Labs, Altay Therapeutics, and Arpeggio Bio.